McKesson Corporation (MCK) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
McKesson Corporation · Health Care · ref. ETF XLV · 52 calls · price $890.51
What the company does: McKesson Corporation provides healthcare services in the United States and internationally.
📈 McKesson Corporation (MCK) stock price
$890.51+30.8% over range
Aug 28, 25low $681.02 · high $995.69Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 10 analysts
📊 JPI status : McKesson Corporation has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 MCK price target & analyst consensus — price $891
The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$1080+21.3%
Median target · of 9 targets$1000+12.3%
Lowest target · 1 firm of 9$845-5.1%
Current price$890.51
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
889%
$933 ↔ $1080
Below
111%
$845
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Citigroup — 66% of its targets hit on this sector (508 calls tested). It aims for $1,000 (+12 %), call made on July 25, 2026, maturing on July 25, 2027 (34 d ago).
The 5 reliable analysts
$1,000+12 %
The 4 other firms
$1,000+12 %
How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $1,000 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 10 ratings (last 6 months)
Strong Buy00%
Buy880%
Hold220%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 MCK price target all
All 52 calls, one by one, with our verdict on each firm.
→ See all 52 targets, analyst by analyst💡 The best analysts on MCK most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in MCK? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about McKesson Corporation? The JPI assistant answers using our backtest data.
💰 McKesson Corporation dividend: yield, history & growth › open the full page
0.43%annual yield
📈 Steady dividend — 18 yrs of consecutive dividend increases
That's ~$3.28 per share per year.
📈 McKesson Corporation fundamentals: valuation, margins & growth › open the full page
P/E 24.0Net margin 1.1 %Revenue growth +7.7 %Average P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 1 %
2024
Rev +12%Profit −16%
2025
Rev +16%Profit +10%
2026
Rev +12%Profit +45%
🔎 Detailed analyses
🏛️ Which US Congress members hold McKesson Corporation (MCK)?
7 Congress members have disclosed MCK buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Lois Frankel 3× · 45%Josh Gottheimer 3× · 56%Dean Phillips 1× · 39%Gilbert Cisneros 1× · 48%Earl Blumenauer 1× · 38%Kathy Manning 1× · 43%William Keating 1× · 43%
✅ Historical analyst reliability on MCK
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Leerink Partners ↗ | 100% | +38.0% | 3 |
| TD Cowen ↗ | 100% | +33.5% | 4 |
| UBS ↗ | 100% | +31.3% | 11 |
| ISI Group | 100% | +30.9% | 3 |
| Argus Research ↗ | 100% | +29.2% | 6 |
| Morgan Stanley ↗ | 97% | +29.7% | 29 |
| Baird ↗ | 92% | +24.6% | 12 |
| Citigroup ↗ | 90% | +32.0% | 10 |
| Evercore ISI Group ↗ | 86% | +21.9% | 7 |
| Goldman Sachs ↗ | 80% | +36.2% | 5 |
See the other 10 firms
| Jefferies ↗ | 0% | -25.3% | 2 |
| Standpoint Research | 50% | -0.1% | 2 |
| Cowen & Co. | 50% | +0.1% | 2 |
| Raymond James ↗ | 50% | +5.5% | 2 |
| Barclays ↗ | 54% | +14.0% | 13 |
| B of A Securities ↗ | 56% | +5.0% | 9 |
| JP Morgan ↗ | 60% | +15.8% | 10 |
| Mizuho ↗ | 67% | +17.1% | 3 |
| Deutsche Bank ↗ | 70% | +17.8% | 10 |
| Credit Suisse | 80% | +24.6% | 10 |
📊 What $1,000 invested in McKesson Corporation would be worth › open the full page
In short — $1,000 invested in McKesson Corporation 10 years ago would be worth $3,831 today, i.e. +14%/yr on average. Best year: 2022 (+51%), worst: 2018 (-29%). Price performance, excluding dividends.
If I'd invested $1,000 in McKesson Corporation
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,326 | +33% |
| 3 years ago | $2,014 | +101% |
| 5 years ago | $4,345 | +334% |
Return by year (McKesson Corporation)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -8% | $921 (-8%) |
| 2025 | +44% | $1,326 (+33%) |
| 2024 | +23% | $1,632 (+63%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on McKesson Corporation
Loading news…
📋 All analyst calls on MCK
Filtered on — · ✕ show all
▲ Overweight · 🎯$1000
Price at call : $838.75 — upside +19%
Today : $890.51 — upside +12%
🎯 on MCK : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
RBC Capital ↗
Aug 19, 26
■ Sector Perform neutral · not a buy · 🎯$845
Price at call : $838.75 — gap to target +1%
Today : $890.51 — gap to target -5%
🎯 on MCK : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
Wells Fargo ↗
Aug 11, 26
■ Equal-Weight neutral · not a buy · 🎯$933
Price at call : $901.77 — gap to target +3%
Today : $890.51 — gap to target +5%
🎯 on MCK : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
▲ Buy · 🎯$1006
Price at call : $869.58 — upside +16%
Today : $890.51 — upside +13%
🎯 on MCK : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Buy · 🎯$1080
Price at call : $869.58 — upside +24%
Today : $890.51 — upside +21%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Evercore ISI Group ↗
Aug 6, 26
▲ Outperform · 🎯$1000
Price at call : $869.58 — upside +15%
Today : $890.51 — upside +12%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Buy · 🎯$1000
Price at call : $850.06 — upside +18%
Today : $890.51 — upside +12%
🎯 on MCK : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
▲ Buy · 🎯$989
Price at call : $814.04 — upside +21%
Today : $890.51 — upside +11%
🎯 on MCK : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 21, 27
matures : Jul 21, 27
See the other 44 calls, newest to oldest
▲ Overweight · 🎯$925
Price at call : $787.19 — upside +18%
Today : $890.51 — upside +4%
🎯 on MCK : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jun 10, 27
matures : Jun 10, 27
▲ Buy · 🎯$945
Price at call : $760.57 — upside +24%
Today : $890.51 — upside +6%
🎯 on MCK : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
Wells Fargo ↗
May 12, 26
■ Equal-Weight neutral · not a buy · 🎯$812
Price at call : $734.69 — gap to target +11%
Today : $890.51 — gap to target -9%
🎯 on MCK : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
▲ Buy · 🎯$1050
Price at call : $725.17 — upside +45%
Today : $890.51 — upside +18%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Overweight · 🎯$1015
Price at call : $725.17 — upside +40%
Today : $890.51 — upside +14%
🎯 on MCK : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Evercore ISI Group ↗
May 8, 26
▲ Outperform · 🎯$850
Price at call : $725.17 — upside +17%
Today : $890.51 — upside -5%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
William Blair ↗
Apr 28, 26
▲ Outperform
🎯 on MCK : no call matured yet · 📊 on Health : 63% · +5.2% (27 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
▲ Buy · 🎯$1000
Price at call : $836.1 — upside +20%
Today : $890.51 — upside +12%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$950
Price at call : $873.43 — upside +9%
Today : $890.51 — upside +7%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
B of A Securities ↗
Apr 6, 26
▲ Buy · 🎯$1000
Price at call : $856.62 — upside +17%
Today : $890.51 — upside +12%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Overweight · 🎯$1050
Price at call : $937.14 — upside +12%
Today : $890.51 — upside +18%
🎯 on MCK : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Overweight · 🎯$1107
Price at call : $953.19 — upside +16%
Today : $890.51 — upside +24%
🎯 on MCK : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
▲ Buy · 🎯$1012
Price at call : $948.68 — upside +7%
Today : $890.51 — upside +14%
🎯 on MCK : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Wells Fargo ↗
Feb 5, 26
■ Equal-Weight neutral · not a buy · 🎯$925
Price at call : $957.8 — gap to target -3%
Today : $890.51 — gap to target +4%
🎯 on MCK : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
■ Neutral neutral · not a buy · 🎯$885
Price at call : $957.8 — gap to target -8%
Today : $890.51 — gap to target -1%
🎯 on MCK : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
▲ Overweight · 🎯$960
Price at call : $813.1 — upside +18%
Today : $890.51 — upside +8%
🎯 on MCK : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Wells Fargo ↗
Nov 10, 25
■ Equal-Weight neutral · not a buy · 🎯$914
Price at call : $859.37 — gap to target +6%
Today : $890.51 — gap to target +3%
🎯 on MCK : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▲ Buy · 🎯$980
Price at call : $851.99 — upside +15%
Today : $890.51 — upside +10%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Outperform · 🎯$927
Price at call : $851.99 — upside +9%
Today : $890.51 — upside +4%
🎯 on MCK : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Morgan Stanley ↗
Nov 6, 25
▲ Overweight · 🎯$916
Price at call : $851.99 — upside +8%
Today : $890.51 — upside +3%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$920
Price at call : $804.59 — upside +14%
Today : $890.51 — upside +3%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
▲ Buy · 🎯$900
Price at call : $781.9 — upside +15%
Today : $890.51 — upside +1%
🎯 on MCK : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
▲ Overweight · 🎯$853
Price at call : $760.55 — upside +12%
Today : $890.51 — upside -4%
🎯 on MCK : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Sep 26, 26
matures : Sep 26, 26
Evercore ISI Group ↗
Sep 24, 25
▲ Outperform · 🎯$825
Price at call : $736.52 — upside +12%
Today : $890.51 — upside -7%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
▲ Buy · 🎯$864
Price at call : $736.52 — upside +17%
Today : $890.51 — upside -3%
🎯 on MCK : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
▲ Buy · 🎯$860
Price at call : $736.52 — upside +17%
Today : $890.51 — upside -3%
🎯 on MCK : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
■ Neutral neutral · not a buy · 🎯$770
Price at call : $736.52 — gap to target +5%
Today : $890.51 — gap to target -14%
🎯 on MCK : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Morgan Stanley ↗
Sep 24, 25
▲ Overweight · 🎯$857
Price at call : $760.58 — upside +13%
Today : $890.51 — upside -4%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Deutsche Bank ↗
Sep 24, 25
▲ Buy · 🎯$856
Price at call : $760.58 — upside +13%
Today : $890.51 — upside -4%
🎯 on MCK : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Wells Fargo ↗
Sep 24, 25
■ Equal-Weight neutral · not a buy · 🎯$816
Price at call : $760.58 — gap to target +7%
Today : $890.51 — gap to target -8%
🎯 on MCK : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Leerink Partners ↗
Sep 24, 25
▲ Outperform · 🎯$850
Price at call : $760.58 — upside +12%
Today : $890.51 — upside -5%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
▲ Buy · 🎯$860
Price at call : $760.58 — upside +13%
Today : $890.51 — upside -3%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
B of A Securities ↗
Sep 24, 25
▲ Buy · 🎯$850
Price at call : $760.58 — upside +12%
Today : $890.51 — upside -5%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Wells Fargo ↗
Aug 13, 25
■ Equal-Weight neutral · not a buy · 🎯$772
Price at call : $663.17 — gap to target +16%
Today : $890.51 — gap to target -13%
🎯 on MCK : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 13, 26
matures : Aug 13, 26
Morgan Stanley ↗
Jul 16, 25
▲ Overweight · 🎯$810
Price at call : $715.74 — upside +13%
Today : $890.51 — upside -9%
Expected +13% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+17.5%
stock +18% · XLV +21%
matured Jul 16, 26
Evercore ISI Group ↗
Jul 9, 25
▲ Outperform · 🎯$800
Price at call : $727.23 — upside +10%
Today : $890.51 — upside -10%
Expected +10% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
+9.0%
stock +9% · XLV +20%
matured Jul 9, 26
Morgan Stanley ↗
Jun 11, 25
▲ Overweight · 🎯$770
Price at call : $730.8 — upside +5%
Today : $890.51 — upside -14%
Expected +5% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+7.3%
stock +7% · XLV +12%
matured Jun 11, 26
Wells Fargo ↗
Jun 3, 25
■ Equal-Weight neutral · not a buy · 🎯$766
Price at call : $714.88 — gap to target +7%
Today : $890.51 — gap to target -14%
🎯 on MCK : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jun 3, 26
matures : Jun 3, 26
B of A Securities ↗
May 9, 25
▲ Buy · 🎯$800
Price at call : $693.46 — upside +15%
Today : $890.51 — upside -10%
Expected +15% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
+4.6%
stock +5% · XLV +8%
matured May 9, 26
▲ Buy · 🎯$805
Price at call : $712.79 — upside +13%
Today : $890.51 — upside -10%
Expected +13% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
+14.4%
stock +14% · XLV +4%
matured Apr 29, 26
B of A Securities ↗
Apr 11, 25
▲ Buy · 🎯$755
Price at call : $689.36 — upside +10%
Today : $890.51 — upside -15%
Expected +10% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
+25.4%
stock +25% · XLV +8%
matured Apr 11, 26
■ Neutral neutral · not a buy · 🎯$690
Price at call : $683.11 — gap to target +1%
Today : $890.51 — gap to target -23%
🎯 on MCK : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Apr 3, 26
matures : Apr 3, 26
Leerink Partners ↗
Oct 7, 24
▲ Outperform · 🎯$630
Price at call : $483.67 — upside +30%
Today : $890.51 — upside -29%
Expected +30% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 55.3% · -4.8% (38 calls)
+55.1%
stock +55% · XLV -4%
matured Oct 7, 25
Leerink Partners ↗
Sep 5, 24
▲ Outperform · 🎯$665
Price at call : $504.17 — upside +32%
Today : $890.51 — upside -25%
Expected +32% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 55.3% · -4.8% (38 calls)
+38.2%
stock +38% · XLV -10%
matured Sep 5, 25
Frequently asked questions
Should I buy McKesson Corporation stock?
This isn't buy advice. For McKesson Corporation, the analyst consensus is "Buy", with an average price target of $1,000 (+12% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on McKesson Corporation). We show the numbers — you decide.
Is it too late to buy McKesson Corporation? How high can it go?
The most bullish analyst target on McKesson Corporation is $1,080 (+21% above today's price); the average is $1,000. That's the upside they see. Check how reliable those analysts have actually been on McKesson Corporation on our site before trusting it.
Is McKesson Corporation still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 20 analysts have a real record on McKesson Corporation, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in McKesson Corporation? The case for and against
The arguments for and against, one by one, from the numbers: why invest in MCK (and why hesitate).
What has McKesson Corporation's past performance been?
Historical returns and a "how much if I had invested" calculator: MCK performance & returns.
Does McKesson Corporation pay a dividend?
Yield, consistency and growth history of the dividend: MCK's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX